Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
EV71 outbreaks persist with rising Asia-Pacific prevalence; leaves open need for enhanced surveillance and vaccine strategies in endemic regions.
Since the discovery of enterovirus 71 (EV71) in 1969, numerous outbreaks have occurred worldwide in countries in Europe, America, and the West Pacific region ([1][1]). Since 1997, the prevalence of EV71 infection in the Asia-Pacific region, especially in southeast Asia, has greatly increased.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: